{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T04:17:01Z","timestamp":1742617021937,"version":"3.40.2"},"reference-count":10,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,13]]},"DOI":"10.1182\/blood.2024027671","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:32:43Z","timestamp":1739464363000},"page":"658-660","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Heme fuels venetoclax resistance in multiple myeloma"],"prefix":"10.1182","volume":"145","author":[{"given":"Mariateresa","family":"Fulciniti","sequence":"first","affiliation":[{"name":"Dana-Farber Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"7","key":"2025032119430548900_bib1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.2024025690","article-title":"Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis","volume":"145","author":"Nair","year":"2025","journal-title":"Blood"},{"issue":"1","key":"2025032119430548900_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s41467-020-15051-z","article-title":"Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma","volume":"11","author":"Bajpai","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"2025032119430548900_bib3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cmet.2019.01.011","article-title":"Systematic dissection of the metabolic-apoptotic interface in AML reveals heme biosynthesis\u00a0to be a regulator of drug sensitivity","volume":"29","author":"Lin","year":"2019","journal-title":"Cell Metabol"},{"issue":"4","key":"2025032119430548900_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","article-title":"Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies","volume":"36","author":"Gui\u00e8ze","year":"2019","journal-title":"Cancer Cell"},{"issue":"30","key":"2025032119430548900_bib5","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/onc.2015.464","article-title":"Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax","volume":"35","author":"Bajpai","year":"2016","journal-title":"Oncogene"},{"issue":"7","key":"2025032119430548900_bib6","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","article-title":"Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"issue":"12","key":"2025032119430548900_bib7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells\u00a0in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"2025032119430548900_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1182\/blood.2022016600","article-title":"Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of\u00a0patient samples","volume":"142","author":"Khalsa","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2025032119430548900_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ccell.2017.11.003","article-title":"Synthetic lethality\u00a0of combined Bcl-2 inhibition and p53 activation in AML: mechanisms and superior antileukemic efficacy","volume":"32","author":"Pan","year":"2017","journal-title":"Cancer Cell"},{"issue":"15","key":"2025032119430548900_bib10","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1182\/bloodadvances.2023012298","article-title":"Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies","volume":"8","author":"Deng","year":"2024","journal-title":"Blood Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/7\/658\/2355520\/blood_bld-2024-027671-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/7\/658\/2355520\/blood_bld-2024-027671-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T20:03:14Z","timestamp":1742587394000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/7\/658\/535439\/Heme-fuels-venetoclax-resistance-in-multiple"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,2,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024027671","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}